Making a difference: 30 years of TDR

Nature Reviews Microbiology

Volumn 6, Issue 5, 2008, Pages 401-407

  Ridley, Robert G ^a   Fletcher, Elaine R ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; AMPHOTERICIN B LIPID COMPLEX; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISIN; ARTESUNATE; CHLOROQUINE; DIETHYLCARBAMAZINE; EFLORNITHINE; FANSIMEF; INSECTICIDE; IVERMECTIN; LEPROSTATIC AGENT; MEFLOQUINE; MILTEFOSINE; MINOCYCLINE; OFLOXACIN; PYRIMETHAMINE; RIFAMPICIN; SULFADOXINE;

AFRICAN TRYPANOSOMIASIS; AGGLUTINATION TEST; ARTICLE; BED NET; CHAGAS DISEASE; CLINICAL TRIAL; COMMUNITY CARE; CURRICULUM; DEVELOPED COUNTRY; DEVELOPING COUNTRY; EDUCATION PROGRAM; FILARIASIS; GENOMICS; HUMAN; INFECTION; INFECTION CONTROL; INTERNATIONAL COOPERATION; LEPROSY; MALARIA; MALARIA CONTROL; MEDICAL RESEARCH; MEDICAL SOCIETY; ONCHOCERCIASIS; PARASITOSIS; PREVALENCE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; TROPICAL DISEASE; VISCERAL LEISHMANIASIS; WORLD HEALTH ORGANIZATION;

ANTI-INFECTIVE AGENTS; ARTEMISININS; BIOMEDICAL RESEARCH; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; EFLORNITHINE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INTERNATIONAL COOPERATION; IVERMECTIN; PARASITIC DISEASES; PROGRAM EVALUATION; TROPICAL MEDICINE; UNITED NATIONS;

EID: 42349094845     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1899     Document Type: Article

References (45)

1. Mahler, H. & Morse, B. in Tropical Diseases, (ed. Dorozynski, A.) inside cover and 1 (WHO, Geneva, 1976).
2. Twenty-seventh World Health Assembly-1. WHO Chron. 28, 303-306 (1974).
3. Lederberg, J. in Biomedical Science and the Third World: Under the Volcano (eds Bloom, B. R. & Cerami, A.) pxix (New York Academy of Sciences, New York, 1989).
4. Goodman, H. in Tropical Disease Research: Progress 1975-94, Highlights 1993-1994. 168 (WHO, Geneva, 1995).
5. World Health Organization. Memorandum of understanding on the administrative and technical structures of the special programmes for research and training in tropical diseases (WHO, Geneva, 1978).
6. Lucas, A. O. Public-private partnerships: Illustrative examples (WHO/ TDR, Geneva, 2000).
7. Ridley, R. G. Product R&D for neglected diseases: Twenty-seven years of WHO/TDR experience with Public-Private partnerships. EMBO Rep. 4, S43-S46 (2003).
8. Special Programme for Research and Training in Tropical Diseases. Tropical disease research. A global partnership. Eighth programme report: The first ten years with highlights of the 1985-86 biennium (WHO/ TDR, Geneva, 1987).
9. Godal, T. Fighting the parasites of poverty: Public research, private industry and tropical diseases. Science 264, 1864-1866 (1994).
10. Lucas, A. O. in Tropical Disease Research: Progress 1975-94, Highlights 1993-1994. 3-8 (WHO, Geneva, 1995).
11. Fletcher, E. in Making a Difference: 30 Years of Research and Capacity-Building in Tropical Diseases 1-105 (WHO/TDR, Geneva, 2007).
12. Special Programme for Research and Training in Tropical Diseases. TDR third external review - final report (WHO/TDR, Geneva, 1988).
13. Omura, S. & Crump, A. The life and times of ivermectin - a success story. Nature Rev. Microbiol. 2, 984-989 (2004).
14. Otero, E. et al. Report of the second external review committee (WHO/TDR, Geneva, 1988).
15. Special Programme for Research and Training in Tropical Diseases. TDR towards the year 2000: Strategic considerations (WHO/TDR, Geneva, 1992).
16. Godal, T. in Biomedical Science and the Third World: Under the Volcano (eds Bloom, B. R. & Cerami, A.) 318-324 (New York Acadamy of Science, New York 1989).
17. Olliaro, P. & Taylor, W. R. J. Antimalarial compounds: From bench to bedside. J. Exp. Biol. 206, 3753-3759 (2003).
18. Olliaro, P. & Taylor, W. R. J. Developing artemisinin-based drug combinations for the treatment of drug-resistant falciparum malaria. A review. J. Postgrad. Med. 50, 40-44 (2004).
19. AFR Reports. Pan-African Study group on onchocercal skin disease: The importance of onchocercal skin disease - report of a multi-country study (WHO, Geneva, 1995).
20. Ngoumou, P. & Walsh, J. F. A Manual for Rapid Epidemiology Mapping Of Onchocerciasis (WHO/TDR, Geneva, 1993).
21. Remme, J. H. F. Research for control: The onchocerciasis experience. Trop. Med. Int. Health 9, 243-254 (2004).
22. UNESCO science report 2005 [online] http://www.unesco.org/science/psd/ publication/science_report2005.pdf (2005).
23. Cattani, J. & Lengeler, C. in Paediatrics Vol. 16 (ed. David, T. J.) 105-119 (Churchill-Livingston, London, 1998).
24. Special Programme for Research and Training in Tropical Diseases. TDR third external review - final report (WHO/TDR, Geneva, 1998).
25. Morel, C. Reaching maturity - 25 years of TDR. Parasitol. Today 16, 522-526 (2000).
26. Nwaka, S. & Hudson, A. Innovative lead discovery strategies for tropical diseases. Nature Rev. Drug Discov. 5, 941-955 (2006).
27. Joint Action Forum. Final Communique of the 13th Session of the Joint Action Forum of the African Programme for Onchocerciasis Control (APOC, Brussels, 2007).
28. Trouiller, P. et al. Drug development for neglected diseases: A deficient market and public health policy failure. Lancet 359 2188-2194 (2002).
29. Fletcher, E. in Making a Difference - 30 Years of Research and Capacity-Building in Tropical Diseases 96-99 (WHO/TDR, Geneva, 2007).
30. Ridley. R. G. Research on infectious diseases requires better coordination. Nature Med. 10, 1-4 (2004).
31. Ridley, R. G. & Toure, Y. Winning the drugs war. Nature 430, 942-943 (2004).
32. Special Programme for Research and Training in Tropical Diseases. Fourth external review of TDR (WHO/TDR, Geneva. 2006).
33. Special Programme for Research and Training in Tropical Diseases. Ten-year vision and strategy. (WHO/TDR, Geneva, 2006).
34. World Health Organization. Tropical diseases today - the challenge and the opportunity (WHO, Geneva, 1975).
35. Malaria R&D Alliance. Malaria research & development, an assessment of global investment, program for appropriate technology in health [online] http://www.mmv.org/IMG/pdf/ RD_Exec_Summary_Final.pdf (2005).
36. Rawlins, M. D. Cutting the cost of drug development. Nature Rev. Drug Discov. 3, 360-364 (2004).
37. Fletcher, E. in Making a Difference - 30 Years of Research and Capacity-Building in Tropical Diseases 89-92 (WHO/TDR, Geneva, 2007).380
38. Macer, D. Ethical, legal and social issues of genetically modified disease vectors in public health (WHO/TDR, Geneva, 2003).
39. El-Sayid, N. M. et al. The genome sequence of Trypanosoma cruzi etiologic agent of Chagas disease. Science 309, 409-415 (2005).
40. Berriman, M. et al. The genome of the African trypanosome Trypanosoma brucei. Science 309, 416-422 (2005).
41. Ivens, A. C. et al. The genome of the kinetoplastid parasite, Leishmania major. Science 309, 436-442 (2005).
42. Holt, R. A. et al. The genome sequencing of the malaria mosquito Anopheles gambiae. Science 298, 129-149 (2002).
43. Morel, C. The mosquito genome, a breakthrough for public health. Science 298, 79 (2002).
44. Remme, J. H. F. et al. in Disease Control Priorities in Developing Countries 2nd edn (eds Jamison, D. T., Breman, J. G. & Measham, A. R.) 433-449 (Oxford Univ. Press, New York, 2006).
45. WHO/CTD/TDR. Strategies for control of lymphatic filariasis infection and disease. [online] http://www.who.int/tdr/diseases/lymphfil/ direction.htm (1994).